Not all patients with LCH need treatment. For instance, some patients have only a single issue with no sign of disease elsewhere. In these patients, the disease will probably go away on its own.
For those children who need treatment, chemotherapy has been considered the standard therapy. However, some LCH patients do not respond to chemotherapy. In an attempt to improve outcomes, scientists at Cincinnati Children’s have devised an innovative treatment for LCH patients that is an alternative to chemotherapy. The new approach involves taking one of two drugs (dabrafenib or trametinib) by mouth. This option has shown promising results without the side effects caused by chemotherapy.
Why Choose Us?
Our customized treatment plans are specific to each patient we see. After a patient has been diagnosed with LCH, doctors meet as a team to discuss possible treatment options and create a comprehensive plan based upon your child’s individual needs.